AGIO

Agios Pharmaceuticals News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Agios Pharmaceuticals Inc AGIO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.45 -0.96% 46.28 18:00:21
Open Price Low Price High Price Close Price Prev Close
47.23 46.06 47.40 46.28 46.73
more quote information »

Recent News

Date Time Source Heading
9/10/202112:23EDGARConfidential Treatment Order (ct Order)
8/30/202107:00GLOBEAgios To Present at September Investor Conferences
8/26/202108:33SEEKThermo Fisher wins FDA nod for companion diagnostic..
8/17/202116:01GLOBEAgios Announces FDA Acceptance and Priority Review of New..
8/09/202115:24EDGARAmended Statement of Ownership (sc 13g/a)
7/29/202110:57EDGARQuarterly Report (10-q)
7/29/202107:17EDGARCurrent Report Filing (8-k)
7/29/202107:09SEEKAgios Pharmaceuticals EPS misses by $0.12
7/29/202107:00GLOBEAgios Reports Business Highlights and Second Quarter 2021..
7/15/202107:00GLOBEAgios to Webcast Conference Call of Second Quarter 2021..
6/28/202107:00GLOBEAgios Submits Marketing Authorisation Application to..
6/23/202117:29EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202107:00GLOBEAgios Launches myAgios® Patient Support Services for..
6/21/202116:19EDGARStatement of Changes in Beneficial Ownership (4)
6/21/202116:01EDGARCurrent Report Filing (8-k)
6/21/202108:21SEEKAgios submits mitapivat application in U.S. for pyruvate..
6/21/202107:42DJNAgios Files for FDA OK of Mitapivat in PK Deficiency
6/21/202107:00GLOBEAgios Submits New Drug Application to FDA for Mitapivat for..
6/11/202117:01EDGARStatement of Changes in Beneficial Ownership (4)
6/11/202108:39SEEKAgios's mitapivat shows positive action in Phase 2..
6/11/202107:25EDGARCurrent Report Filing (8-k)
6/11/202103:00GLOBEAgios Announces Updated Data from ACTIVATE and ACTIVATE-T..
6/09/202116:07EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202116:08EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202116:08EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202116:07EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202116:07EDGARStatement of Changes in Beneficial Ownership (4)
5/24/202116:46EDGARStatement of Changes in Beneficial Ownership (4)
5/24/202116:46EDGARStatement of Changes in Beneficial Ownership (4)
5/24/202116:46EDGARStatement of Changes in Beneficial Ownership (4)
5/24/202116:44EDGARStatement of Changes in Beneficial Ownership (4)
5/18/202116:12EDGARStatement of Changes in Beneficial Ownership (4)
5/12/202110:00GLOBEAgios to Present Updated Data from Clinical Trials of..
5/07/202116:19EDGARAmended Quarterly Report (10-q/a)
4/29/202108:04SEEKAgios posts wider Q1 loss as R&D expenses rise
4/29/202107:29EDGARCurrent Report Filing (8-k)
4/29/202107:05SEEKAgios Pharmaceuticals EPS misses by $0.04
4/29/202107:00GLOBEAgios Reports Business Highlights and First Quarter 2021..
4/28/202112:16SEEKAgios Pharmaceuticals Q1 2021 Earnings Preview
4/20/202116:10EDGARStatement of Changes in Beneficial Ownership (4)
4/15/202116:47EDGARStatement of Changes in Beneficial Ownership (4)
4/15/202107:00GLOBEAgios to Webcast Conference Call of First Quarter 2021..
4/08/202116:08EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/08/202116:05EDGARProxy Statement (definitive) (def 14a)
4/06/202116:41EDGARCurrent Report Filing (8-k)
4/02/202116:48EDGARCurrent Report Filing (8-k)
4/01/202114:13SEEKAgios to repurchase $345 million stock from Bristol-Myers
4/01/202107:00GLOBEAgios Announces Closing of Oncology Business Sale to Servier
3/25/202116:14SEEKAgios shareholders approve oncology business sale to Servier..
3/25/202116:01GLOBEAgios Shareholders Approve Sale of Oncology Business to..
See more news about this stock »
Your Recent History
NASDAQ
AGIO
Agios Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211016 03:31:28